Concepedia

Maryna Marynchenko

MM

16

Publications

1.1K

Citations

14

H-Index

2002

Active since

Affiliations

Analysis Group (United States)(Current)

Eli Lilly (United States)

Takeda (United States)

Forest Research Institute

Tulane University

Maryna Marynchenko is an author at Analysis Group (United States) specializing in medicine, psychiatry, and depression.

Top concepts

Publications per year

2002–2015

16

Publications

16

Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis

Alexandra L. Quittner, Jie Zhang, Maryna Marynchenko et al. · CHEST Journal · 2014 · 237 citations

, , +4

Attention-Deficit/Hyperactivity Disorder: Increased Costs for Patients and Their Families

Andrine R. Swensen, Howard G. Birnbaum, Kristina Secnik et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2003 · 188 citations

, , +5

Economic Implications of Treatment-Resistant Depression Among Employees

Patricia K. Corey‐Lisle, Howard G. Birnbaum, Maryna Marynchenko et al. · PharmacoEconomics · 2004 · 110 citations

, , +6

Identification of a Claims Data "Signature" and Economic Consequences for Treatment-Resistant Depression

Patricia K. Corey‐Lisle, Howard G. Birnbaum, Maryna Marynchenko et al. · The Journal of Clinical Psychiatry · 2002 · 84 citations

Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs

Morgan Bron, Maryna Marynchenko, Hongbo Yang et al. · Postgraduate Medicine · 2012 · 78 citations

Rows per page

1–5 of 16